<DOC>
	<DOCNO>NCT00963092</DOCNO>
	<brief_summary>RATIONALE : Collecting store sample tissue , blood , saliva patient cancer test laboratory may help study cancer future . PURPOSE : This research study collect blood tissue sample patient stomach cancer , esophageal cancer , gastroesophageal junction cancer , study laboratory , store future study .</brief_summary>
	<brief_title>Study Blood Tissue Samples From Patients With Stomach Cancer , Esophageal Cancer , Gastroesophageal Junction Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To set population-based gastric esophageal cancer cohort comprehensive epidemiological , clinical , pathological data order identify novel genetic environmental risk factor cancer use association study design . - To establish blood-based epidemiological resource parallel tumor sample population-based series gastric esophageal cancer case . - Compare difference genetic susceptibility gene accord site esophago-gastric cancer ( e.g. , distal gastric , proximal gastric , junctional esophageal tumor ) histopathological sub-type . - Test exist molecular hypothesis determine whether common genetic variant candidate gene predispose gastric esophageal cancer compare frequency variant cancer patient control . - Generate new hypothesis genetic certain environmental determinant , explore potential impact cancer disease risk range environmental factor measure plasma ( e.g. , antibodies various infective agent , marker systemic inflammation , marker oxidation ) , examine gene-environment interaction . - Refine understanding risk factor identify ( e.g. , chronic Helicobacter pylorus infection smoking ) examine interact genetic determinant disease . - Define proportion gastric cancer incidence attributable mutation know predispose gene , E-cadherin . - Obtain data molecular profile tumor ( mostly paraffin-embedded , rarely frozen ) use dense array technology , therefore enable study interaction germline polymorphism tumor somatic genotype upon tumor behavior , response treatment , patient outcome . OUTLINE : This multicenter study . Patients healthy control complete epidemiological questionnaire , provide blood sample plasma genetic analysis , may also provide saliva sample . Tumor sample ( form paraffin block material , rare case , frozen ) may also obtain hospital patient underwent surgery . White blood cell assay DNA/RNA isolation look genetic variant . DNA extract saliva look genetic variant . Plasma/serum sample analyze look proteins serological marker . Tumor sample use review histology type . Nucleic acid extract tumor sample section ; retrieval small ( 0.6 mm ) core section use construct tissue microarray analyze immunohistochemistry FISH . Peer Reviewed Funded Endorsed Cancer Research UK . PROJECTED ACCRUAL : A total 1,000 patient per cancer ( gastric esophageal ) 2,000 control accrue study .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Must meet 1 follow criterion : Diagnosis gastric esophageal adenocarcinoma Diagnosed within past 5 year May include gastroesophageal junction tumor Spouse relative patient Samples collect European Prospective Investigation Cancer ( EPIC ) study Patients approach participate study regardless current treatment curative palliative , medical surgical , currently followup clinical appointment PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>adenocarcinoma gastroesophageal junction</keyword>
	<keyword>recurrent gastric cancer</keyword>
	<keyword>stage IV gastric cancer</keyword>
	<keyword>adenocarcinoma stomach</keyword>
	<keyword>adenocarcinoma esophagus</keyword>
	<keyword>recurrent esophageal cancer</keyword>
	<keyword>stage I esophageal cancer</keyword>
	<keyword>stage II esophageal cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>stage IV esophageal cancer</keyword>
	<keyword>stage IA gastric cancer</keyword>
	<keyword>stage IB gastric cancer</keyword>
	<keyword>stage IIA gastric cancer</keyword>
	<keyword>stage IIB gastric cancer</keyword>
	<keyword>stage IIIA gastric cancer</keyword>
	<keyword>stage IIIB gastric cancer</keyword>
	<keyword>stage IIIC gastric cancer</keyword>
</DOC>